uncontrolled moderate to severe
Showing 1 - 1 of 1
Allergic Asthma, Uncontrolled Moderate to Severe Trial in Iran, Islamic Republic of (Omalizumab (CinnaGen), Omalizumab
Completed
- Allergic Asthma
- Uncontrolled Moderate to Severe
- Omalizumab (CinnaGen)
- Omalizumab (Genentech, Inc., USA and Novartis Pharmaceuticals Corp, Switzerland)
-
Ahvaz, Iran, Islamic Republic of
- +21 more
Apr 3, 2023